- Research article
- Open Access
Inactivation of NMD increases viability of sup45 nonsense mutants in Saccharomyces cerevisiae
BMC Molecular Biologyvolume 8, Article number: 71 (2007)
The nonsense-mediated mRNA decay (NMD) pathway promotes the rapid degradation of mRNAs containing premature termination codons (PTCs). In yeast Saccharomyces cerevisiae, the activity of the NMD pathway depends on the recognition of the PTC by the translational machinery. Translation termination factors eRF1 (Sup45) and eRF3 (Sup35) participate not only in the last step of protein synthesis but also in mRNA degradation and translation initiation via interaction with such proteins as Pab1, Upf1, Upf2 and Upf3.
In this work we have used previously isolated sup45 mutants of S. cerevisiae to characterize degradation of aberrant mRNA in conditions when translation termination is impaired. We have sequenced his7-1, lys9-A21 and trp1-289 alleles which are frequently used for analysis of nonsense suppression. We have established that sup45 nonsense and missense mutations lead to accumulation of his7-1 mRNA and CYH2 pre-mRNA. Remarkably, deletion of the UPF1 gene suppresses some sup45 phenotypes. In particular, sup45-n upf1Δ double mutants were less temperature sensitive, and more resistant to paromomycin than sup45 single mutants. In addition, deletion of either UPF2 or UPF3 restored viability of sup45-n double mutants.
This is the first demonstration that sup45 mutations do not only change translation fidelity but also acts by causing a change in mRNA stability.
Two translation termination factors, eRF1 and eRF3, participate in termination of protein synthesis in eukaryotes (reviewed in ). In S. cerevisiae they are encoded by SUP45 and SUP35, respectively (reviewed in ). In eukaryotes, a single factor, eRF1 (Sup45 in yeast), decodes all three stop codons, while eRF3 (Sup35 in yeast) stimulates termination through a GTP-dependent mechanism by forming a complex with eRF1.
Eukaryotic cells possess a mechanism known as nonsense-mediated mRNA decay (NMD) to recognize and degrade mRNA molecules that contain premature termination codon (PTC) (reviewed in [3–5]). The NMD process is mediated by the trans- acting factors Upf1, Upf2 and Upf3 [6–11], all of which directly interact with eRF3; while only Upf1 interacts with eRF1 [12, 13]. Using in vitro competition experiments, it has been demonstrated that Upf2, Upf3 and eRF1 actually compete with each other for binding to eRF3 . Deletion of any one of the three UPF genes selectively stabilizes mRNAs that are degraded by the NMD pathway without affecting other mRNAs [6, 7, 9–11]. Genetic studies have shown that Upf1, Upf2, and Upf3 act as obligate partners in the NMD pathway; this means that NMD only occurs when all components are present (reviewed in [14, 15]). Mutations or deletions of UPF genes lead to an increased frequency of nonsense suppression at termination codons in a variety of yeast genes (reviewed in ). A mutation in the GTP-binding motifs of eRF3 impairs the eRF1-binding ability and not only causes a defect in translation termination but also slows normal and nonsense-mediated mRNA decay, suggesting that GTP/eRF3-dependent termination exerts its influence on the subsequent mRNA degradation . Taken together these results suggest a direct link between the termination complex and the mRNA stability.
Both eRF1 and eRF3 are essential for viability of yeast cells and deletion of the C-terminal part of each protein separately lead to lethality (reviewed in ). Nonsense sup45 mutations have been obtained in the presence of SUQ5 suppressor tRNA . However, we have isolated non-lethal nonsense mutations in the SUP45 gene of S. cerevisiae which lead to decreased level of eRF1 . Nonsense mutations were also obtained in the SUP35 gene [19, 20]. Here, we show that sup45 nonsense and missense mutations have an inhibitory effect on NMD. Our observation that loss of Upf1 suppresses many of the pleiotropic phenotypes caused by mutations in SUP45 allowed us to discuss the role of the Upf complex in translation termination.
The sup45 mutations cause a general decrease in the efficiency of NMD
In previous work, we have isolated non-lethal nonsense and missense mutations in the essential SUP45 gene of S. cerevisiae which lead to a high level of suppression . Since a direct link between the termination complex and the mRNA stability was proposed, we examined the efficiency of NMD in these mutants by testing whether a decrease in eRF1 level will lead to accumulation of PTC-containing transcripts.
The abundance of the precursor and mature CYH2 mRNA levels can be used to monitor NMD, because it has been shown that inefficiently spliced CYH2 pre-mRNA containing a premature termination codon is degraded by NMD pathway . In the present paper, we show that the accumulation of his7-1 mRNA is affected by NMD pathway. The strain 1B-D1606 in which sup45 mutants were obtained, contains nonsense mutations in HIS7, LYS9 and TRP1 genes. As shown in Table 1, sequence analysis of the his7-1, lys9-A21 and trp1-289 alleles identified the presence of single nonsense mutations. It is known that destabilization of mRNAs by NMD depends on the position of the nonsense codon and the presence of a DSE (downstream destabilizing element) downstream of mutation (reviewed in ). Indeed, while mRNAs with nonsense codons occurring in the last 20 to 30% of the coding region retain their wild-type decay rates, mRNAs harboring PTC in the first two-third of the gene are subject to degradation by NMD. The his7-1 nonsense mutation is located at the beginning of HIS7 mRNA and is followed by two putative DSE (Table 1), suggesting that his7-1 transcript could be a substrate for NMD.
To check if his7-1 transcript is affected by NMD, two isogenic strains were constructed harboring the his7-1 allele together with UPF1 or upf1 Δ. For this purpose, the strain 5B-D1645 (his7-1 upf1Δ) was transformed with pRS316 and pRS316/UPF1 plasmids. The mean steady-state level of the his7-1 mRNA was 3.5 fold higher in the upf1 Δ cells than in UPF1 cells (Fig. 1, upper panel). However, the level of wild-type HIS7 mRNA was not affected by deletion of UPF1 (see Additional file 1, figure 1A). The steady-state level of ade1-14, another nonsense-containing transcript, did not depend on deletion of UPF1 (Fig. 1, middle panel). Therefore, the deletion of UPF1 gene affects the his7-1 transcript in precisely the same manner that it affects the CYH2 pre-mRNA demonstrating that his7-1 is a potential substrate for NMD. Earlier it was shown that deletion of UPF1 gene promotes suppression of some but not all nonsense mutations . Indeed, we did not detect suppression of his7-1 mutation on SC-HIS medium in strain 5B-D1645 bearing upf1Δ (see additional file 1 Fig. 1B).
We studied NMD efficiency in sup45 mutant strains by examination of CYH2 and his7-1 mRNA levels. First, we have shown that the mRNA level of wild-type HIS7 mRNA in sup45-n mutants and upf1Δ mutants is not changed (see additional file 1 Fig. 1B). Next, we used strains harboring nonsense mutations sup45- 102, 104, 105, 107, which lead to decrease of eRF1 full-length protein level  and the sup45-103 (L21S) missense-mutation . Total RNA was isolated from mutants and analyzed by Northern blots using probes specific for CYH2 and his7-1 mRNA. Strains bearing sup45-n mutations had a significantly increased CYH2 pre-mRNA/RNA ratio (1.7 ± 0.1 to 2.1 ± 0.2) compared with that of wild-type SUP45 strain (ratio of 1). A similar increase was also observed for sup45-103 missense mutant (1.8 ± 0.1) (Fig. 2A). Similarly, the relative abundance of his7-1 mRNA in the sup45-n mutant strains, normalized using ACT1 mRNA, ranged from 1.8 ± 0.3 to 2.8 ± 0.4 compared with that of wild-type SUP45 strain (ratio of 1) (Fig. 2B). The strain harboring missense mutation sup45-103 was also characterized by the accumulation of the his7-1 transcript (1.8 ± 0.1). This effect was weaker than that observed for UPF1 deletion which causes 4 and 3.5 fold increases in the CYH2 pre-mRNA/RNA ratio and the accumulation of his7-1 mRNA, respectively (Fig. 1), however it appears specific for NMD substrates since the amounts of other nonsense-containing transcripts (ade1-14 and lys9-A21) were not significantly changed in sup45 mutants (see Additional file 2). We also observed a significant increase of the CYH2 pre-mRNA/RNA ratio and of his7-1 mRNA level in strains bearing sup35 nonsense and missense mutations (data not shown). Taken together, these results demonstrate that both nonsense and missense mutations in SUP45 decrease the efficiency of mRNA degradation by NMD thus leading to accumulation of mRNAs containing PTCs.
Increased viability of sup45 nonsense mutants in the absence of UPF1
Previously, we have shown that sup45 nonsense mutants are viable in different genetic backgrounds . However, the efficiency of plasmid shuffle was significantly lower in the case of mutant sup45-n alleles compared to plasmid bearing wild-type SUP45 gene  indicating that sup45-n mutations imperfectly replace SUP45. To assess the effects of double sup45 upf1 mutations on viability of corresponding strains we performed plasmid shuffle analysis using strains bearing single sup45 mutations or sup45 in combination with upf1Δ (see Materials and Methods).
Two nonsense mutations resulting in different stop codons (sup45-102 (UAA) and sup45-107 (UGA)) and one missense mutation (sup45-103) were used to perform plasmid shuffle experiments. Two isogenic yeast strains 1A-D1628 (sup45Δ pRS316/SUP45) and 1-1A-D1628 (sup45Δ upf1Δ pRS316/SUP45) were transformed with the pRS315 plasmids bearing the wild-type SUP45 gene or different sup45 mutations. Transformants were then subjected to plasmid shuffle analysis to verify whether strains containing the sup45 alleles could lose the plasmid carrying the wild-type gene. In the sup45Δ strain, all transformants were able to grow in the presence of 5-FOA, indicating that all tested mutations can replace wild-type SUP45. However, as previously described , plasmid shuffle was less efficient with sup45 mutations than with wild-type SUP45. Surprisingly, introduction of upf1Δ mutation lead to increased viability of sup45 mutants (Fig. 3, 5-FOA). We did not observe difference in growth between wild-type and sup45 mutants on medium selective for both plasmids (Fig. 3, -L-U). In order to check that deletion of UPF1 does not lead to higher production of eRF1 protein in double sup45 upf1Δ mutants which could explain the increased viability of these mutants, we analyzed eRF1 protein level by western blot. As shown in figure 3B, deletion of UPF1 does not affect the level of eRF1 protein in sup45 mutants.
The same experiment was repeated using two other strains, 3b-D1658 (sup45Δ pRS316/SUP45) and 3v-D1658 (sup45Δ upf1Δ pRS316/SUP45). These strains were transformed with the pRS315 plasmids bearing the wild-type SUP45 gene or different sup45 mutations, Leu+ Ura+ transformants were patched on 5-FOA medium to select against pRS316/SUP45 plasmid (see Additional file 3, Fig. 3AB). The same results were obtained. Again, introduction of upf1Δ mutation leads to increased viability of sup45 mutants (see Additional file 3, Fig. 3AB). Western blot analyses showed that deletion of UPF1 did not affect levels of eRF1 and eRF3 proteins in sup45 mutants (see additional file 3 Fig. 3C). Thus, deletion of UPF1 confers selective survival advantages to sup45 nonsense mutants.
Deletion of the UPF1 gene suppresses several sup45 phenotypes
It is known that mutations in the SUP45 gene lead to suppression of nonsense mutations and also to many phenotypic changes including high or low temperature sensitivity, respiratory efficiency and sensitivity to aminoglycoside antibiotics such as paromomycin (reviewed in ). It has been previously reported that loss the UPF1 gene results in the suppression of some but not all of nonsense mutations. In addition, deletion of UPF1 does not confer sensitivity to paromomycin , an aminoglycoside antibiotic that induces translational misreading. We therefore compared phenotypes of single sup45 and double sup45 upf1Δ mutants, previously obtained by plasmid shuffle, for suppression efficiency, temperature sensitivity and sensitivity to paromomycin. As previously described [18, 22], nonsense sup45-102 and sup45-107 and missense sup45-103 mutations are temperature sensitive. We observed that deletion of UPF1 suppressed temperature sensitivity of both sup45-102 and sup45-107 nonsense mutants in rich medium. However UPF1 deletion did not suppress temperature sensitivity of sup45-103 missense mutant (Fig. 4A). The observed disparity in effect of UPF1 deletion on temperature sensitivity of nonsense and missense mutants can be connected with different nature of temperature sensitivity in the case of decreased level of eRF1 compared with mutated eRF1. Loss of Upf1 also restored growth of all sup45 mutants on paromomycin media (Fig. 4B). In addition, deletion of UPF1 had an allosuppressor effect on suppression of ade1-14 mutation by sup45 mutations. However deletion of UPF1 alone, in the presence of wild-type copy of the SUP45 gene had no suppressor effect on ade1-14 mutation (Fig. 4C). On YPD medium, all transformants grew indicating that they retained their growth capacity on rich medium (Fig. 4D). Therefore the analysis of sup45 upf1Δ double mutants shows that loss of Upf1 not only affects viability of sup45 mutants but also suppresses several sup45 phenotypes.
Defects of NMD in double mutants sup45 upf1 Δ
We have previously shown that sup45 mutants affect NMD and that UPF1 deletion suppresses several sup45 phenotypes. Therefore, we next examined if UPF1 deletion would have an additional effect on NMD in sup45 mutants. For this purpose, we compared accumulation of CYH2 precursor mRNA in single sup45 mutants and sup45 upf1Δ double mutants. To this end, we transformed strain 3v-D1658 (sup45Δ upf1Δ pRS315/SUP45) and its derivates (sup45Δ upf1Δ pRS315/sup45-n) with plasmids pRS316 or pRS316/UPF1. In the presence of upf1Δ and wild-type SUP45, accumulation of CYH2 precursor increased by 4.6 fold. We found that the presence of sup45 mutations increased the ratio of preCYH2 to mature CYH2 mRNA by 1.9 to 2.3-fold (Fig. 5A,B), in agreement with results obtained previously in a different genetic background (Fig. 2A). Combination of sup45-n mutations and upf1Δ slightly but reproducibly increased the ratio of preCYH2 to mature CYH2 mRNA from 4.6 to 6.0 fold. Therefore, these results indicate that the combination of sup45-n and upf1 mutations together increased accumulation of CYH2 precursor more than either single one.
To compare the effects of single sup45 mutations and the sup45 upf1Δ double mutations on the efficiency of suppression, we replica plated the same transformants that were used for Nothern blots analysis (Fig. 5A) on adenine deprived medium. As shown in another genetic background (Fig. 4C), deletion of UPF1 does not promote suppression of ade1-14 mutation (Fig. 5C) and the combined effects of sup45 mutations and upf1Δ promote increase in the suppression efficiency compared with sup45 mutations alone. As shown in figure 5D, allosuppression of ade1-14 by deletion of UPF1 is not the result of stabilization of ade1-14 mRNA in double sup45 upf1Δ mutants. We also showed that deletion of UPF1 does not affect sup45-n mRNAs and eRF1 as well as eRF3 protein levels (Fig. 5D).
Deletion of either UPF2 or UPF3 increases viability of sup45 nonsense mutants
It has been described that functional NMD requires not only Upf1 but also Upf2 and Upf3 [7, 9–11, 23–25]. To test whether UPF2 or UPF3 deletion will have the same effect on viability of sup45 nonsense mutants as deletion of UPF1, we transformed strains 4a-D1659 (sup45Δ), 4b-D1659 (sup45Δ upf2Δ), 18a-D1660 (sup45Δ) and 3a-D1660 (sup45Δ upf3Δ), all containing pRS316/SUP45 [URA3] plasmid, with pRS315/sup45-n [LEU2] plasmids carrying sup45-102 or sup45-107 mutant alleles. Leu+ Ura+ transformants were selected and plated on leucine deprived medium containing 5-FOA to select against the pRS316/SUP45 [URA3] plasmid. Combining either UPF2 or UPF3 deletion with sup45 mutations results in an enhanced viability of double mutants (Fig. 6AB). Western blot analysis has shown, as in case of UPF1 deletion, that the level of eRF1 and eRF3 proteins was not dependent on the presence of functional UPF2 or UPF3 genes (Fig. 6CD). These results demonstrate that deletion of UPF2 or UPF3 as well as deletion of UPF1, all essential components of NMD pathway, leads to increase viability of sup45-n mutant strains.
In the present work, we have shown that nonsense and missense mutations in the SUP45 gene lead to stabilization of PTC-containing mRNAs degraded by NMD. This is the first demonstration that sup45 mutations do not only change translation fidelity but also acts by causing a change in mRNA stability.
The CYH2 pre-mRNA which contains a premature termination codon was previously shown to be degraded by NMD pathway . We also identified that NMD affects accumulation of his7-1 mRNA. A single A→T mutation in this allele leads to change of codon 229 for UAA. In addition, two imperfect putative DSE are found downstream of this premature stop codon. Using a upf1Δ strain, we demonstrated that the his7-1 transcript is possibly under control of NMD pathway. In order to answer if changes in transcription of HIS7 gene could account for accumulation of his7-1 mRNA, we examined the mRNA level of wild-type HIS7 mRNA in sup45-n mutants and upf1Δ mutants. Deletion of upf1 as well as sup45 mutations leads to accumulation of his7-1 mRNA but do not affect mRNA level of wild-type HIS7 mRNA. Accordingly, a genome-wide analysis performed in strains depleted for NMD showed that wild-type HIS7 mRNA (and also ADE1 and LYS9 mRNAs) is not affected in strains deleted for upf1 .
Here, we demonstrate that accumulation of his7-1 and CYH2 precursor mRNAs in cells bearing sup45 mutations was much higher than that observed in the wild-type strain. But, sup45 mutations do not promote accumulation of other nonsense-containing transcripts, such as ade1-14 or lys9-A21, despite efficient suppression of these mutations, as well as his7-1 [18, 22]. This result indicates that simply increasing read-through efficiency does not result in a general increase in the abundance of PTC-containing mRNAs but that sup45 mutations specifically affect PTC-containing mRNA subjected to NMD. We observed that the abundance of his7-1 and CYH2 precursor mRNAs in cells bearing sup45 mutations was lower compared to those in the upf1Δ strain. This difference between upf1Δ and sup45 mutants could be explained by the complete absence of Upf1 protein in the upf1Δ strain leading to complete inactivation of NMD and by the presence of some functional eRF1 protein in sup45 mutants which is necessary for cell viability [18, 22]. Indeed, we previously reported that in the case of sup45-n, the level of eRF1 is decreased compared to wild-type and in the case of sup45 missense mutants the level of eRF1 is unchanged but its functionality is altered. These results demonstrate that eRF1 participates in NMD.
Recently, it was shown the importance of the second translation termination factor (eRF3) for NMD and interaction of both eRF1 and eRF3 with Upf proteins. Upf1 protein interacts with the polypeptide release factors eRF3 and eRF1 while they are still present in the ribosome-bound termination complex, providing a direct link between the termination complex and the NMD machinery [12, 13]. Both Upf2 and Upf3 interact with eRF3, but not with eRF1; and Upf2, Upf3 and eRF1 compete with each other in vitro for binding to eRF3 [12, 13]. eRF3 also interacts with poly(A)-binding protein (PABP) [27, 28], furthermore, eRF3 regulates the initiation of normal mRNA decay at the poly(A) tail-shortening step through the interaction with PABP . Thus, eRF3 can mediate normal and nonsense-mediated mRNA decay through its association with Pab1 and Upf1 and therefore was proposed as a key mediator between translation termination and NMD . Moreover, it was previously shown that a weak translation termination due to [PSI+] (a prion form of eRF3) antagonizes the effects of NMD . A first indication for a link between translation termination and NMD came from observations that decay of PTC-containing mRNAs can be antagonized by tRNAs that suppress termination . Data have shown that normal termination is distinct from premature termination and this difference is dependent upon the presence of Upf1 at the premature termination codon . Our results together with data about eRF1-Upf1 interaction [12, 13] demonstrate that eRF1 as well as eRF3 is an essential factor linking translation termination and NMD. Recognition of stop codons is a common event necessary for the two processes. Since it is established that eRF1 plays a crucial role in translation termination by directly recognizing stop codons (reviewed in ), eRF1 could have an identical function in NMD by recognition of PTC.
We observed that the combination of upf1Δ and sup45-n mutations leads to an increase in CYH2 precursor mRNA abundance that was higher than in upf1Δ and sup45-n single mutants. A similar additive effect on stabilization of nonsense-containing mRNA was shown for combination of upf1Δ and [PSI+] . Therefore, a possible explanation for this additive effect of upf1Δ and sup45-n mutations could be that eRF1 is required for both normal and nonsense-mediated mRNA decay, as it was shown for eRF3 .
It has been shown that mutation in eRF3 which impairs eRF3 binding to eRF1 affected mRNA decay . In the present paper, we show that the missense mutation sup45-103 (L21S) alters degradation of PTC-containing mRNAs by NMD. However, we have previously shown that this mutation does not affect the eRF1-eRF3 interaction , indicating that this allele has an inhibitory effect on NMD that is independent on eRF1-eRF3 binding. This result demonstrates that eRF1 mutation affecting PTC-containing mRNA decay by NMD does not obligatory alters the eRF1-eRF3 interaction.
A role for the Upf1 protein, essential for NMD, in translation termination first became evident when a set of mutations were isolated in the UPF1 gene that separated the mRNA decay function from its activity in modulating premature termination [33, 34]. Subsequent studies have shown that deletion of either UPF2 or UPF3 can also lead to a nonsense suppression phenotype [7, 9, 11, 13, 35]. In addition, it was shown that upf1Δ mutation causes a general decrease in the efficiency of translation termination at UAG, UAA, and UGA stop codons .
In this work, we have shown that deletion of UPF1 does not affect ade1-14 mRNA level, but results in allosuppression of ade1-14 mutation in sup45 nonsense mutants therefore revealing that deletion of UPF1 has a synergistic effect with sup45-n mutants. Similar allosuppressor effect has also been shown for deletion of UPF1 in combination with [PSI+] [30, 36]. Based on this additive effect, Keeling et al.  proposed that upf1Δ mutation and [PSI+] influence the termination process in distinct ways. Our results suggest that this could be also the case for upf1Δ and sup45 mutations.
We found that deletion of the UPF1 gene affects several other sup45 phenotypes, such as temperature sensitivity, paromomycin sensitivity and viability of sup45 mutants. It is known that deletion of UPF1 gene in yeast does not cause any detectable phenotypic effects except respiratory deficiency  and nonsense suppression [7, 9, 13, 33–35]. Also telomere length is affected by deletions of UPF1-3 genes . How UPF1 deletion could affect sup45 phenotypes? We can not exclude an indirect effect of UPF1 deletion on sup45 phenotypes. It has been reported that NMD controls the mRNA levels of several hundred of wild-type genes [24, 26]. One can hypothesize that depletion of Upf1 could affect the expression of some translation apparatus components (e.g. tRNA genes) which themselves influence the viability of sup45 mutants. Indeed, the presence of SUQ5 mutation, a mutant suppressor tRNASer, increases the viability of sup45-n mutants . Alternatively, since inactivation of the NMD pathway by upf1Δ mutation does not increase the steady-state levels of wild-type and mutant SUP45 mRNAs and does not cause a change in the amount of eRF1 protein, we propose that the effect of NMD on sup45 phenotypes is probably via a change in the stoichiometry of factors involved in translation termination and NMD. In contrast to mammals, Upf proteins of S. cerevisiae are present at very low intracellular concentrations . Considering that in sup45-102 and sup45-107 nonsense mutants the amount of eRF1 was estimated as 8% and 17% of wild-type level, respectively , in mutant cells eRF1 and Upf1 proteins are probably present in stoichiometric amounts. Possibly, in wild-type cells, Upf1 is not preventing normal termination because its amount is ten times lower than eRF1, but in the case of their presence in stoichiometric amounts in sup45 nonsense mutants binding of Upf1 to eRF1 could result in a defective complex formation that blocks termination. This hypothesis is supported by finding that viability of sup45 nonsense mutants depends also on Upf2 or Upf3 proteins. There is a possibility that effect of Upf2 or Upf3 depletion is indirect and is under control of Upf1. It was shown that in mammalian cells a depletion of Upf2 or Upf3 reduces the amount of the phosphorylated form of Upf1 possibly preventing Upf1 dissociation from eRF3 and eRF1 . Phosphorylation of Upf1 and Upf2 was also shown in S. cerevisiae [41, 42], an indication that this mechanism might operate in yeast cells as well.
From recent studies, it appears more and more clear that translation termination and mRNA stability are intimately linked and our results demonstrate that eRF1 is also an essential factor linking these two processes.
In the present work, we have shown hat nonsense and missense mutations in SUP45 gene lead to stabilization of CYH2, a PTC-containing pre-mRNA degraded by NMD, and to accumulation of his7-1 mRNA. At the same time, sup45 mutations do not promote accumulation of other nonsense-containing transcripts, such as ade1-14 or lys9-A21, despite efficient suppression of these mutations. Thus sup45 mutations specifically affect PTC-containing mRNA subjected to NMD. Deletion of UPF1 results in allosuppression of ade1-14 mutation in sup45 nonsense mutants and leads to an increase in CYH2 pre-mRNA abundance therefore revealing that deletion of UPF1 has a synergistic effect with sup45-n mutants. This is the first demonstration that sup45 mutations do not only change translation fidelity but also acts by causing a change in mRNA stability.
Models explaining increased viability of sup45 nonsense mutants in the absence of Upf1, Upf2 or Upf3 proteins are proposed. First, the depletion of Upf1 could affect the expression of some translation apparatus components (e.g. tRNA genes) which themselves influence the viability of sup45 mutants. Second, a change in the stoichiometry of factors involved in translation termination and NMD provides the effect of NMD on sup45 phenotypes.
Yeast strains, plasmids and growth conditions
The S. cerevisiae strains used in this study are listed in Table 2. Previously characterized sup45 mutations [18, 22] were used in this study, among them the following nonsense mutations (sup45-n): sup45-102 (53 Tyr→TAA); sup45-104 (283 Leu→TAA); sup45-105 (385 Glu→TAA); sup45-107 (317 Leu→TGA); as well as missense mutation (sup45-m): sup45-103 (Leu21Ser). All sup45 mutations were selected by spontaneous reversions of two nonsense mutations, his7-1 and lys9-A21 in strain 1B-D1606. Strains Y06214, Y01905, Y04702 are from Euroscarf; other strains were obtained during this study. Strain 5B-D1645 was recovered from the meiotic progeny of D1645, obtained by mating Y06214 and 16A-D1608. Strains D1658, D1659, D1660 were generated by mating of strains Y06214, Y01905, Y04702 with 1A-D1628. Tetrads were dissected and segregants were used for further study. Yeast strain 1-1A-D1628 was generated by using a one-step gene replacement method. The UPF1 gene was deleted by the removal of the entire open reading frame and the insertion of the kanMX gene by using PCR-based gene deletion approach  with plasmid pFA6a-kanMX. The following primers were used for PCR: F1 (AATATACTTTTTATATTACATCAATCATTGTCATTATCAACGGATCCCCGGGTTAATTAA) and R1 (AAGCCAAGTTTAACATTTTATTTTAACAGGGTTCACCGAAGAATTCGAGCTCGTTTAAAC). Yeast strain 1A-D1628 was transformed with the fragment generated by PCR. KanR transformants were screened by PCR. Yeast strains were grown either in standard rich or synthetic culture medium  at 25°C. Transformants were grown in the media selective for plasmid maintenance (SC-Trp, SC-Leu, SC-Ura). Suppression of nonsense mutations was estimated by growth at 25°C on synthetic media lacking the corresponding amino acids. For plasmid shuffle, selective medium containing 1 mg/ml 5-fluoroorotic acid (5-FOA, Sigma) was used. Yeast transformation was performed as described . Plasmid pRS316/UPF1 contains UPF1 gene under its own promoter .
The haploid SUP45::HIS3 [CEN URA3 SUP45] and SUP45::HIS3 UPF::kanMX4 [CEN URA3 SUP45] strains were used in "plasmid shuffle". These strains were transformed with [CEN LEU2 sup45] plasmids. Transformants, selected on -Ura-Leu medium, were velveteen replica plated onto 5-FOA medium, which counterselects against URA3 plasmids . Growth was also assayed using serial dilutions of overnight cultures with OD600 = 1. Serially (10-fold) diluted yeast cell cultures were spotted on plates containing 5-FOA to determine the ability of the sup45 mutant alleles to support cell growth in the presence and absence of any one of three UPF genes. The wild-type yeast SUP45 gene carried on the URA3 plasmid eliminates because 5-FOA is toxic to cells expressing the URA3 gene. The same serially diluted cultures were also spotted on plates lacking leucine and uracil to estimate the total number of cells analyzed.
Sequencing of the alleles his7-1, lys9-A21 and trp1-289
Yeast DNA was prepared using genomic DNA purification Kit (Promega). DNA fragments, corresponding to ORFs were amplified with the following primers:
HIS7 (202 GGCAGCTATTGAAGTAGCAGTATCCAG and
LYS9 (192 CAGCAATAGATGATAGAAAGTAGCACAG and
TRP1 (188 GAGGGAGGGCATTGGTGACTATTG and
For each allele at least two independent PCR-products were sequenced using the following primers:
HIS7 (195 GATGTACGTACTAATGACCAAGGTG and
LYS9 (197 GCTAAATACTGGAAAGACGGAAAG and
TRP1 (177 GTCTGTTATTAATTTCACAGGTAGTTC).
Analysis of mRNA steady-state levels
Total RNA was prepared by hot-phenol extraction method from yeast culture grown in YPD medium to log phase OD600 = 0.5-0.8 as described . Five micrograms of each RNA sample were separated on a 1.2% agarose gel, containing 3% formaldehyde and transferred to nylon membrane, Z-probe (Bio-Rad). SUP45, HIS7, CYH2 and ACT1 transcripts were detected using gene-specific 32P-radiolabelled DNA probes. Radioactive signals were directly detected and quantified by STORM Phosphor Imager system (Molecular dynamics, USA).
Probes were synthesized using following oligos:
82 CATTTCGGCTTGTCTCC and 83 TCTGGCATCTAGTGATTAAATTC (for SUP45), 195 GATGTACGTACTAATGACCAAGGTG and 196 GTTACTTCATCCGCACCCTGTTGG (for HIS7), 186 GACTAGAAAGCACAGAGGTCACGTC and 187 GACTAGAAAGCACAGAGGTCACGTC (for CYH2), 175 CGAAGACTGAACTGGACGGTATATTG and 176 CCCTGTCAATGTTTCATAAGCCTC for ADE1, 192 CAGCAATAGATGATAGAAAGTAGCACAG and 193 CAAGCTTCAGGAACTACACTCTC (for LYS9), 215 AGGCTGTAATGGCTTTCTGGTGGGATGGGA and 216 GATATGTGCTATCCCGGCCGCCTCCATCAC (for scR1).
Hind III-Xba I fragment of plasmid pSK/actin was used as a probe for ACT1 (M. Vedel, Institut of M. Curie, Paris).
Protein isolation, SDS-PAGE electrophoresis, and western blotting were performed as described previously . Antibodies specific to eRF1 and eRF3 were described previously [18, 20], monoclonal anti-α-tubulin antibodies were described before . eRF1 and eRF3 and α-tubulin signals were detected using alkaline-phosphatase-coupled anti-rabbit immunoglobulin G secondary antibodies (Jackson) (for eRF1 and eRF3) or alcaline-phosphatase-coupled anti-mouse immunoglobulin G secondary antibodies (Jackson) (for tubulin) by Amersham ECF system (Amersham Pharmacia Biotech). Signals were quantified with STORM 840 Phosphor-Imager (Molecular dynamics, USA) and ImageQuantNT 5.2 software.
Kisselev L, Ehrenberg M, Frolova L: Termination of translation: interplay of mRNA, rRNAs and release factors? EMBO J 2003, 22: 175-182. 10.1093/emboj/cdg017
Inge-Vechtomov S, Zhouravleva G, Philippe M: Eukaryotic release factors (eRFs) history. Biol Cell 2003, 95: 195-209. 10.1016/S0248-4900(03)00035-2
Baker KE, Parker R: Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol 2004, 16: 293-299. 10.1016/j.ceb.2004.03.003
Wilkinson MF: A new function for nonsense-mediated mRNA-decay factors. Trends Genet 2005, 21: 143-148. 10.1016/j.tig.2005.01.007
Amrani N, Dong S, He F, Ganesan R, Ghosh S, Kervestin S, Li C, Mangus DA, Spatrick P, Jacobson A: Aberrant termination triggers nonsense-mediated mRNA decay. Biochem Soc Trans 2006, 34: 39-42. 10.1042/BST0340039
Leeds P, Peltz SW, Jacobson A, Culbertson MR: The product of the yeast UPF1 gene is required for rapid turnover of mRNAs containing a premature translational termination codon. Genes Dev 1991, 5: 2303-2314. 10.1101/gad.5.12a.2303
Leeds P, Wood JM, Lee BS, Culbertson MR: Gene products that promote mRNA turnover in Saccharomyces cerevisiae. Mol Cell Biol 1992, 12: 2165-2177.
Peltz SW, Brown AH, Jacobson A: mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor. Genes Dev 1993, 7: 1737-1754. 10.1101/gad.7.9.1737
Cui Y, Hagan KW, Zhang S, Peltz SW: Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. Genes Dev 1995, 9: 423-436. 10.1101/gad.9.4.423
He F, Jacobson A: Identification of a novel component of the nonsense-mediated mRNA decay pathway by use of an interacting protein screen. Genes Dev 1995, 9: 437-454. 10.1101/gad.9.4.437
Lee BS, Culbertson MR: Identification of an additional gene required for eukaryotic nonsense mRNA turnover. Proc Natl Acad Sci USA 1995, 92: 10354-10358. 10.1073/pnas.92.22.10354
Czaplinski K, Ruiz-Echevarria MJ, Paushkin SV, Han X, Weng Y, Perlick HA, Dietz HC, Ter-Avanesyan MD, Peltz SW: The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev 1998, 12: 1665-1677.
Wang W, Czaplinski K, Rao Y, Peltz SW: The role of Upf proteins in modulating the translation read-through of nonsense-containing transcripts. EMBO J 2001, 20: 880-890. 10.1093/emboj/20.4.880
Culbertson MR: RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet 1999, 15: 74-80. 10.1016/S0168-9525(98)01658-8
Gonzalez CI, Bhattacharya A, Wang W, Peltz SW: Nonsense-mediated mRNA decay in Saccharomyces cerevisiae . Gene 2001, 274: 15-25. 10.1016/S0378-1119(01)00552-2
Kobayashi T, Funakoshi Y, Hoshino S, Katada T: The GTP-binding release factor eRF3 as a key mediator coupling translation termination to mRNA decay. J Biol Chem 2004, 279: 45693-45700. 10.1074/jbc.M405163200
Stansfield I, Eurwilaichitr L, Akhmaloka , Tuite MF: Depletion in the levels of the release factor eRF1 causes a reduction in the efficiency of translation termination in yeast. Mol Microbiol 1996, 20: 1135-1143. 10.1111/j.1365-2958.1996.tb02634.x
Moskalenko SE, Chabelskaya SV, Inge-Vechtomov SG, Philippe M, Zhouravleva GA: Viable nonsense mutants for the essential gene SUP45 of Saccharomyces cerevisiae . BMC Mol Biol 2003, 4: 2. 10.1186/1471-2199-4-2
Bradley ME, Bagriantsev S, Vishveshwara N, Liebman SW: Guanidine reduces stop codon read-through caused by missense mutations in SUP35 or SUP45 . Yeast 2003, 20: 625-632. 10.1002/yea.985
Chabelskaya S, Kiktev D, Inge-Vechtomov S, Philippe M, Zhouravleva G: Nonsense mutations in the essential gene SUP35 of Saccharomyces cerevisiae are non-lethal. Mol Genet Genomics 2004, 272: 297-307. 10.1007/s00438-004-1053-1
He F, Peltz SW, Donahue JL, Rosbash M, Jacobson A: Stabilization and ribosome association of unspliced pre-mRNAs in a yeast upf1 – mutant. Proc Natl Acad Sci USA 1993, 90: 7034-7038. 10.1073/pnas.90.15.7034
Moskalenko SE, Zhuravleva GA, Soom MI, Shabel'skaia SV, Volkov KV, Zemlianko OM, Philippe M, Mironova LN, Inge-Vechtomov SG: [Characterization of missense mutations in the SUP45 gene of Saccharomyces cerevisiae encoding translation termination factor eRF1]. Genetika 2004, 40: 599-606.
Pulak R, Anderson P: mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev 1993, 7: 1885-1897. 10.1101/gad.7.10.1885
Lelivelt MJ, Culbertson MR: Yeast Upf proteins required for RNA surveillance affect global expression of the yeast transcriptome. Mol Cell Biol 1999, 19: 6710-6719.
Gatfield D, Unterholzner L, Ciccarelli FD, Bork P, Izaurralde E: Nonsense-mediated mRNA decay in Drosophila: at the intersection of the yeast and mammalian pathways. EMBO J 2003, 22: 3960-3970. 10.1093/emboj/cdg371
He F, Li X, Spatrick P, Casillo R, Dong S, Jacobson A: Genome-wide analysis of mRNAs regulated by the nonsense-mediated and 5' to 3' mRNA decay pathways in yeast. Mol Cell 2003, 12: 1439-1452. 10.1016/S1097-2765(03)00446-5
Cosson B, Couturier A, Chabelskaya S, Kiktev D, Inge-Vechtomov S, Philippe M, Zhouravleva G: Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [ PSI+] propagation. Mol Cell Biol 2002, 22: 3301-3315. 10.1128/MCB.22.10.3301-3315.2002
Hoshino S, Imai M, Kobayashi T, Uchida N, Katada T: The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-Poly(A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein. J Biol Chem 1999, 274: 16677-16680. 10.1074/jbc.274.24.16677
Hosoda N, Kobayashi T, Uchida N, Funakoshi Y, Kikuchi Y, Hoshino S, Katada T: Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J Biol Chem 2003, 278: 38287-38291. 10.1074/jbc.C300300200
Keeling KM, Lanier J, Du M, Salas-Marco J, Gao L, Kaenjak-Angeletti A, Bedwell DM: Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae . RNA 2004, 10: 691-703. 10.1261/rna.5147804
Losson R, Lacroute F: Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 1979, 76: 5134-5137. 10.1073/pnas.76.10.5134
Amrani N, Ganesan R, Kervestin S, Mangus DA, Ghosh S, Jacobson A: A faux 3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature 2004, 432: 112-118. 10.1038/nature03060
Weng Y, Czaplinski K, Peltz SW: Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol Cell Biol 1996, 16: 5477-5490.
Weng Y, Czaplinski K, Peltz SW: Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover. Mol Cell Biol 1996, 16: 5491-5506.
Maderazo AB, He F, Mangus DA, Jacobson A: Upf1p control of nonsense mRNA translation is regulated by Nmd2p and Upf3p. Mol Cell Biol 2000, 20: 4591-4603. 10.1128/MCB.20.13.4591-4603.2000
Wilson MA, Meaux S, Parker R, van Hoof A: Genetic interactions between [ PSI+] and nonstop mRNA decay affect phenotypic variation. Proc Natl Acad Sci USA 2005, 102: 10244-10249. 10.1073/pnas.0504557102
Altamura N, Groudinsky O, Dujardin G, Slonimski PP: NAM7 nuclear gene encodes a novel member of a family of helicases with a Zn-ligand motif and is involved in mitochondrial functions in Saccharomyces cerevisiae . J Mol Biol 1992, 224: 575-587. 10.1016/0022-2836(92)90545-U
Lew JE, Enomoto S, Berman J: Telomere length regulation and telomeric chromatin require the nonsense-mediated mRNA decay pathway. Mol Cell Biol 1998, 18: 6121-30.
Culbertson MR, Neeno-Eckwall E: Transcript selection and the recruitment of mRNA decay factors for NMD in Saccharomyces cerevisiae . RNA 2005, 11: 1333-1339. 10.1261/rna.2113605
Kashima I, Yamashita A, Izumi N, Kataoka N, Morishita R, Hoshino S, Ohno M, Dreyfuss G, Ohno S: Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev 2006, 20: 355-367. 10.1101/gad.1389006
de Pinto B, Lippolis R, Castaldo R, Altamura N: Overexpression of Upf1p compensates for mitochondrial splicing deficiency independently of its role in mRNA surveillance. Mol Microbiol 2004, 51: 1129-1142. 10.1046/j.1365-2958.2003.03889.x
Wang W, Cajigas IJ, Peltz SW, Wilkinson MF, Gonzalez CI: Role for Upf2p phosphorylation in Saccharomyces cerevisiae nonsense-mediated mRNA Decay. Mol Cell Biol 2006, 26: 3390-3400. 10.1128/MCB.26.9.3390-3400.2006
Longtine MS, McKenzie A III, Demarini DJ, Shah NG, Wach A, Brachat A, Philippsen P, Pringle JR: Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae . Yeast 1998, 14: 953-961. 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
Guthrie C, Fink GR: Guide to yeast genetics and molecular biology. San Diego: Academic Press; 1991.
Gietz RD, Schiestl RH, Willems AR, Woods RA: Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 1995, 11: 355-360. 10.1002/yea.320110408
Atkin AL, Schenkman LR, Eastham M, Dahlseid JN, Lelivelt MJ, Culbertson MR: Relationship between yeast polyribosomes and Upf proteins required for nonsense mRNA decay. J Biol Chem 1997, 272: 22163-22172. 10.1074/jbc.272.35.22163
Kaiser C, Michaelis S, Mitchell A, Cold Spring HL: Methods in yeast genetics. Cold Spring Harbor laboratory course manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1994.
Woods A, Sherwin T, Sasse R, MacRae TH, Baines AJ, Gull K: Definition of individual components within the cytoskeleton of Trypanosoma brucei by a library of monoclonal antibodies. J Cell Sci 1989,93(Pt 3):491-500.
This work was supported by grant from CRDF ST-012, S.C. is supported by grants from NATO and FEBS. We are very grateful to M. Culbertson and K. Volkov for kindly providing plasmid constructs, H.B.Osborne for critical reading of the manuscript, D. Kiktev, A. Petrova and J-P. Gagné for technical assistances. We also thank Michel Philippe for his support.
SC, carried out the molecular genetic studies and drafted the manuscript, VG, constructed all strains with UPF gene deletions, SM and CLG participated in the molecular genetic studies, GZ, designed the study, performed plasmid shuffle analysis and wrote the manuscript. All authors read and approved the final manuscript.